Interventional Oncology Devices Market Expansion Forecast Reaching $3.5 Billion By 2030 At 7% CAGR

Global Interventional Oncology Devices Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Interventional Oncology Devices Market In 2026, And How Will Its Value Evolve By 2030?

The interventional oncology devices market has observed robust expansion in recent years. This market is forecasted to increase from $2.5 billion in 2025 to $2.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. The historical growth of this market can be linked to several factors including rising cancer incidence rates, the broadening of interventional radiology practices, enhancements in imaging technologies, increasing adoption of minimally invasive oncology treatments, and the establishment of specialized oncology centers.

The interventional oncology devices market is projected to experience substantial expansion in the coming years, reaching a valuation of $3.5 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period can be linked to several factors, including the escalating demand for targeted cancer treatments, increased capital allocation in precision oncology, the proliferation of outpatient facilities for cancer care, a wider uptake of integrated interventional therapies, and innovations in ablation and embolization technologies. Key trends expected during the forecast timeframe encompass the expanding utilization of image-guided devices for tumor ablation, a surge in the application of minimally invasive approaches for cancer treatment, a broader implementation of embolization techniques, the proliferation of precision oncology interventions, and improved incorporation of advanced imaging support systems.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Key Drivers Are Fueling The Growth Of The Interventional Oncology Devices Market?

The increasing occurrence of cancer is projected to drive the expansion of the interventional oncology devices market in the future. Cancer constitutes a range of illnesses defined by the unchecked proliferation and dissemination of atypical cells within the organism. These atypical cells have the capacity to develop into masses or tumors. The widespread presence of cancer escalates the need for interventional oncology devices, given their application in the identification, therapy, and handling of cancer, aiding in timely discovery, classification, and observation. As an illustration, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that within Australia, the count of diagnosed cancer cases climbed from 160,570 in 2022 to 164,694 in 2023, signifying a considerable increase during that year. This rising trajectory underscores the expanding occurrence of cancer across the nation. Consequently, the substantial incidence of cancer is fueling the expansion of the interventional oncology devices market.

How Is The Interventional Oncology Devices Market Broken Down By Segment Categories?

The interventional oncology devices market covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

What Trends Are Influencing The Interventional Oncology Devices Market?

Leading companies in the interventional oncology devices market are concentrating on technologies, including tissue volume, to improve diagnostic precision and treatment effectiveness in oncology procedures. Tissue volume defines the quantity of biological tissue gathered during a biopsy. Bigger tissue volumes can yield more exhaustive samples, thus enhancing the accuracy of diagnoses and the efficacy of treatment strategies. For example, in June 2023, Argon Medical, a US-based medical device company, unveiled the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage can gather up to 35% more samples compared to major competitors, which subsequently lessens the requirement for multiple passes during biopsies. This attribute is vital for acquiring sufficient tissue samples necessary for an accurate diagnosis.

Which Players Are Present In The Interventional Oncology Devices Market Space?

Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation

Get The Full Interventional Oncology Devices Market Report:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Which Region Represents The Largest Share Of The Interventional Oncology Devices Market?

North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Interventional Oncology Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2026, By The Business Research Company

Cardiovascular Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model